Literature DB >> 11258553

Corticosteroid pretreatment prevents small intestinal mucosal lesion induced by acetic acid-perfusion model in rats.

I Pacheco1, M Otaka, M Jin, H Sasahara, A Iwabuchi, M Odashima, N Konishi, I Wada, O Masamune, S Watanabe.   

Abstract

One of the important problems in experimentally induced small intestinal lesions is that there is no reproducible model of diffuse and stable mucosal lesion. In this paper, we studied in detail the effects of continuous perfusion of various concentrations of acetic acid on the rat small intestinal mucosa. In order to evaluate its applicability for screening of the preventive effect of drugs on gut damage, we also evaluated the efficacy of corticosteroid pretreatment in preventing acetic acid-induced mucosal lesion. Male Sprague-Dawley rats were fasted for 12 hr, and the small intestinal lumen was perfused with 1%, 1.5%, 2.5%, 3%, 3.75% (pH 2.4-2.6) acetic acid or saline (control) at 1 ml/min for 15 min. In separate experiments, the effect of preadministration of budesonide (0.5 or 0.75 mg/kg/day) and prednisone (0.75 mg/kg/day) on 1.5% acetic acid-induced mucosal damage was investigated. Macroscopic and microscopic lesions occurred diffusely in a concentration-dependent fashion. Histological findings revealed signs of transmural inflammation characterized by mucosal-submucosal edema, ulceration, and neutrophil infiltration. Mucosal-submucosal height had an inverse relation with the acetic acid concentrations perfused. Myeloperoxidase activity levels increased several-fold in the acetic acid-perfused groups. Corticosteroid pretreatment prevented microscopic damage and was associated with reduction of MPO activity levels in 1.5% acetic acid-perfused rats. We conclude that this simple and reproducible model could be applied for the screening of new drugs in the gastrointestinal tract in which large numbers of animals are taken into account.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11258553     DOI: 10.1023/a:1005519304829

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

Review 1.  Intestinal mucins in health and disease.

Authors:  J F Forstner
Journal:  Digestion       Date:  1978       Impact factor: 3.216

2.  Neutrophil-derived oxidants mediate formyl-methionyl-leucyl-phenylalanine-induced increases in mucosal permeability in rats.

Authors:  C von Ritter; M B Grisham; M Hollwarth; W Inauen; D N Granger
Journal:  Gastroenterology       Date:  1989-09       Impact factor: 22.682

3.  Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study.

Authors:  R Löfberg; P Rutgeerts; H Malchow; C Lamers; A Danielsson; G Olaison; D Jewell; O Ostergaard Thomsen; H Lorenz-Meyer; H Goebell; H Hodgson; T Persson; C Seidegård
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

4.  Inhibition of prednisolone metabolism by cyclosporine in kidney-transplanted patients.

Authors:  E Langhoff; S Madsen; H Flachs; K Olgaard; J Ladefoged; E F Hvidberg
Journal:  Transplantation       Date:  1985-01       Impact factor: 4.939

5.  Topical and systemic glucocorticoid potencies of budesonide, beclomethasone dipropionate and prednisolone in man.

Authors:  S A Johansson; K E Andersson; R Brattsand; E Gruvstad; P Hedner
Journal:  Eur J Respir Dis Suppl       Date:  1982

6.  Regulation of intestinal goblet cell secretion. II. A survey of potential secretagogues.

Authors:  M R Neutra; L J O'Malley; R D Specian
Journal:  Am J Physiol       Date:  1982-04

7.  Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models.

Authors:  J E Krawisz; P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-12       Impact factor: 22.682

8.  Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver.

Authors:  G Jönsson; A Aström; P Andersson
Journal:  Drug Metab Dispos       Date:  1995-01       Impact factor: 3.922

9.  A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis.

Authors:  A Danielsson; R Löfberg; T Persson; L Salde; R Schiöler; O Suhr; R Willén
Journal:  Scand J Gastroenterol       Date:  1992       Impact factor: 2.423

10.  Preventive effect of immunosuppressive agents against indomethacin-induced small intestinal ulcers in rats.

Authors:  T Matsumoto; M Iida; S Nakamura; K Hizawa; F Kuroki; M Fujishima
Journal:  Dig Dis Sci       Date:  1994-04       Impact factor: 3.199

View more
  4 in total

1.  Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage.

Authors:  Corrado Blandizzi; Matteo Fornai; Rocchina Colucci; Gianfranco Natale; Valter Lubrano; Cristina Vassalle; Luca Antonioli; Gloria Lazzeri; Mario Del Tacca
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

2.  Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage.

Authors:  M Fornai; G Natale; R Colucci; M Tuccori; G Carazzina; L Antonioli; S Baldi; V Lubrano; A Abramo; C Blandizzi; M Del Tacca
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-08-04       Impact factor: 3.000

3.  Dexamethasone mediates protection against acute pancreatitis via upregulation of pancreatitis-associated proteins.

Authors:  Emad Kandil; Yin-Yao Lin; Martin-H Bluth; Hong Zhang; Gabriel Levi; Michael-E Zenilman
Journal:  World J Gastroenterol       Date:  2006-11-14       Impact factor: 5.742

4.  Consequences of adrenalectomy on small intestine trophic parameters in aged and young rats: evidence of defective adaptation by aging and lack of corticoids.

Authors:  Benoit Foligne; Francoise Senegas-Balas; Raffaele Cursio; Chantal Cayuela; Jean-Michel Antoine; Nathalie Rolf-Petersen; Daniel Balas
Journal:  Dig Dis Sci       Date:  2003-06       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.